IGC Pharma, Inc.
IGC· NYSE
IGCIGC Pharma, Inc.
Filed Aug 18, 2011 · 10-Q · 49 days after period end · 0001185185-11-001390
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Revenue | $1.06M | $1.13M |
| Net Income | -$869.20K | -$591.17K |
| EPS Diluted | -$0.04 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IGC Pharma, Inc. · CIK 1326205 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 18, 2011 · 49 d after period end
